Natera Presents Breast Cancer Data at SABCS Showing Ability of Signatera (RUO) to Detect Molecular Residual Disease Up to Two Years Prior to Clinical Relapse and Predict Treatment Response
A world of information in every drop
Harnessing the power of DNA
from a single blood sample to improve
the management of reproductive
health, cancer, and organ transplants.
A world of information in every drop
Harnessing the power of DNA
from a single blood sample to improve
the management of reproductive
health, cancer, and organ transplants.
A world of information in every drop
Harnessing the power of DNA
from a single blood sample to improve
the management of reproductive
health, cancer, and organ transplants.
A world of information in every drop
Harnessing the power of DNA
from a single blood sample to improve
the management of reproductive
health, cancer, and organ transplants.
A world of information in every drop
Harnessing the power of DNA
from a single blood sample to improve
the management of reproductive
health, cancer, and organ transplants.
Family of reproductive health genetic tests
Natera® is driven by a passion for improving the path to parenthood with a suite of high-quality products that support families in their journey from preconception, to pregnancy, and birth.
Cutting-edge
oncology research
Natera is developing new tools to revolutionize treatment monitoring, recurrence monitoring, and residual disease detection across many cancer types.
Lab solutions
Natera offers propriety bioinformatic solutions that enable laboratories worldwide to expand their test offerings. Constellation manages security, storage, compliance and computational resources.